Anti-tumor activity of irreversible menin inhibitor, BMF-219, in high-grade B-cell lymphoma and multiple myeloma preclinical models (Abstract #1205)
Apr 12, 2022 from 9:00 AM to 12:30 PM CDT
Session Category: Experimental and Molecular Therapeutics
Session Title: Novel Targets and Pathways
Location: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 24
Poster Board Number: 23
Permanent Abstract Number: 2654
Session Title: Novel Targets and Pathways
Location: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 24
Poster Board Number: 23
Permanent Abstract Number: 2654